Transthyretin Amyloidosis (ATTR) Market, Global Outlook and Forecast 2023-2030

Transthyretin Amyloidosis (ATTR) Market, Global Outlook and Forecast 2023-2030

Published On : december 2023

Email: help@24marketreports.com

Report Studies The global Transthyretin Amyloidosis (ATTR) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Transthyretin Amyloidosis (ATTR) is an autosomal dominant hereditary disease that occurs due to deposition of variant TTR (transthyretin) protein in humans. It is mainly characterized into two main types i.e.

Hereditary ATTR (hATTR) and Wild-Type (wt) ATTR.

Email: help@24marketreports.com

Call: +1(646)-781-7170 (Int'l)

By Types

Hereditary ATTR (HATTR)

Email: help@24marketreports.com

Wild-Type (WT) ATTR

Call: +1(646)-781-7170 (Int'l)

By Applications • Hospitals • Ambulatory Surgical Centers • Diagnostic Centers

$50,000 $40,000

$35,000 $30,000 $25,000

$30,000 $20,000

$20,000 $15,000 $10,000

$10,000 $0

Email: help@24marketreports.com

Call: +1(646)-781-7170 (Int'l)

$5,000 $0

Get in touch help@24marketreports.com

Call :

Call :

E-mail:

+1(646)-781-7170 (Int'l)

+91 8087042414 (Asia)

URL: www.24marketreports.com

Full Report URL: https://www.24marketreports.com/life-sciences/global-transthyretinamyloidosis-forecast-2023-2030-452 ©All Rights Reserved, 24 Market Reports